PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 22, 2024Diabetes Care56 citationsOpen Access

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

View Full Paper
ILIldiko LingvayJDJohn DeanfieldSKSteven E. Kahn

Key Points

Key points are not available for this paper at this time.

Abstract

To evaluate the cardiovascular effects of semaglutide by baseline glycated hemoglobin (HbA1c) and change in HbA1c in a prespecified analysis of Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lingvay et al. (2024) studied this question.

synapsesocial.com/papers/68e63aecb6db6435875ccbefhttps://doi.org/10.2337/dc24-0764
Ask AI
Helpful
Bookmark
Share
View Full Paper